Role of the eye muscles in thyroid eye disease: Identification of the principal autoantigens

Kazuaki Gunji, Sumihara Kubota, Jil Swanson, Jacek Kiljanski, Tomasz Bednarczuk, Sylvia Wengrowicz, Mario Salvi, Jack R. Wall

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Thyroid-associated ophthalmopathy (TAO) is a progressive orbital disorder associated with Graves' hyperthyroidism and, less often, Hashimoto's thyroiditis in which autoantibodies react with orbital antigens and lead to exophthalmos and eye muscle inflammation. Eye muscle (EM) membrane proteins initially reported as 55 and 64 kd are the best markers of ophthalmopathy. The '64-kd protein' is now shown to be the flavoprotein subunit of mitochondrial succinate dehydrogenase and to have a correct molecular weight of 67 kd. We have cloned a fragment of a novel eye muscle protein, which we call G2s, and sequenced 1.4 kb of the full length cDNA. G2s does not share any significant homologies with other reported proteins. The 5.9 kb G2s mRNA, that corresponds to a protein of approximately 220 kd, is expressed in EM, other skeletal muscle and thyroid, but not in other tissues tested. We have also cloned and sequenced a 63-kd eye muscle protein identified as the calcium binding protein calsequestrin. Antibodies against calsequestrin were found in 40% of patients with active ophthalmopathy, but in 0% of normal subjects. Finally, we have sequenced a 19 amino acid fragment of a 55-kd porcine eye muscle membrane protein that exactly matched porcine and human sarcalumenin, a 160-kd glycoprotein localized in the lumen of the longitudinal sarcoplasmic reticulum of the skeletal muscle fiber where it binds calcium. A 53-kd glycoprotein fragment of the molecule corresponds to the 55-kd protein. In a preliminary study, serum antibodies against purified sarcalumenin were detected in 40% of patients with active TAO of less than 1 year duration, but in no controls tested. We propose that the primary autoantigen in TAO is G2s, which would also explain the association of ophthalmopathy with thyroid autoimmunity, and that antibodies against the intracellular proteins flavoprotein, calsequestrin, and sarcalumenin are secondary markers of an immune-mediated reaction in eye muscle in patients with thyroid autoimmunity.

Original languageEnglish
Pages (from-to)553-556
Number of pages4
JournalThyroid
Volume8
Issue number6
Publication statusPublished - 1998

Fingerprint

Eye Proteins
Eye Diseases
Thyroid Diseases
Autoantigens
Muscle Proteins
Calsequestrin
Graves Ophthalmopathy
Muscles
Flavoproteins
Thyroid Gland
Proteins
Autoimmunity
Antibodies
Glycoproteins
Membrane Proteins
Swine
Hashimoto Disease
Calcium-Binding Proteins
Exophthalmos
Succinate Dehydrogenase

ASJC Scopus subject areas

  • Endocrinology

Cite this

Gunji, K., Kubota, S., Swanson, J., Kiljanski, J., Bednarczuk, T., Wengrowicz, S., ... Wall, J. R. (1998). Role of the eye muscles in thyroid eye disease: Identification of the principal autoantigens. Thyroid, 8(6), 553-556.

Role of the eye muscles in thyroid eye disease : Identification of the principal autoantigens. / Gunji, Kazuaki; Kubota, Sumihara; Swanson, Jil; Kiljanski, Jacek; Bednarczuk, Tomasz; Wengrowicz, Sylvia; Salvi, Mario; Wall, Jack R.

In: Thyroid, Vol. 8, No. 6, 1998, p. 553-556.

Research output: Contribution to journalArticle

Gunji, K, Kubota, S, Swanson, J, Kiljanski, J, Bednarczuk, T, Wengrowicz, S, Salvi, M & Wall, JR 1998, 'Role of the eye muscles in thyroid eye disease: Identification of the principal autoantigens', Thyroid, vol. 8, no. 6, pp. 553-556.
Gunji K, Kubota S, Swanson J, Kiljanski J, Bednarczuk T, Wengrowicz S et al. Role of the eye muscles in thyroid eye disease: Identification of the principal autoantigens. Thyroid. 1998;8(6):553-556.
Gunji, Kazuaki ; Kubota, Sumihara ; Swanson, Jil ; Kiljanski, Jacek ; Bednarczuk, Tomasz ; Wengrowicz, Sylvia ; Salvi, Mario ; Wall, Jack R. / Role of the eye muscles in thyroid eye disease : Identification of the principal autoantigens. In: Thyroid. 1998 ; Vol. 8, No. 6. pp. 553-556.
@article{c5d7fb0496b74052bb79f02034a0c8cd,
title = "Role of the eye muscles in thyroid eye disease: Identification of the principal autoantigens",
abstract = "Thyroid-associated ophthalmopathy (TAO) is a progressive orbital disorder associated with Graves' hyperthyroidism and, less often, Hashimoto's thyroiditis in which autoantibodies react with orbital antigens and lead to exophthalmos and eye muscle inflammation. Eye muscle (EM) membrane proteins initially reported as 55 and 64 kd are the best markers of ophthalmopathy. The '64-kd protein' is now shown to be the flavoprotein subunit of mitochondrial succinate dehydrogenase and to have a correct molecular weight of 67 kd. We have cloned a fragment of a novel eye muscle protein, which we call G2s, and sequenced 1.4 kb of the full length cDNA. G2s does not share any significant homologies with other reported proteins. The 5.9 kb G2s mRNA, that corresponds to a protein of approximately 220 kd, is expressed in EM, other skeletal muscle and thyroid, but not in other tissues tested. We have also cloned and sequenced a 63-kd eye muscle protein identified as the calcium binding protein calsequestrin. Antibodies against calsequestrin were found in 40{\%} of patients with active ophthalmopathy, but in 0{\%} of normal subjects. Finally, we have sequenced a 19 amino acid fragment of a 55-kd porcine eye muscle membrane protein that exactly matched porcine and human sarcalumenin, a 160-kd glycoprotein localized in the lumen of the longitudinal sarcoplasmic reticulum of the skeletal muscle fiber where it binds calcium. A 53-kd glycoprotein fragment of the molecule corresponds to the 55-kd protein. In a preliminary study, serum antibodies against purified sarcalumenin were detected in 40{\%} of patients with active TAO of less than 1 year duration, but in no controls tested. We propose that the primary autoantigen in TAO is G2s, which would also explain the association of ophthalmopathy with thyroid autoimmunity, and that antibodies against the intracellular proteins flavoprotein, calsequestrin, and sarcalumenin are secondary markers of an immune-mediated reaction in eye muscle in patients with thyroid autoimmunity.",
author = "Kazuaki Gunji and Sumihara Kubota and Jil Swanson and Jacek Kiljanski and Tomasz Bednarczuk and Sylvia Wengrowicz and Mario Salvi and Wall, {Jack R.}",
year = "1998",
language = "English",
volume = "8",
pages = "553--556",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Role of the eye muscles in thyroid eye disease

T2 - Identification of the principal autoantigens

AU - Gunji, Kazuaki

AU - Kubota, Sumihara

AU - Swanson, Jil

AU - Kiljanski, Jacek

AU - Bednarczuk, Tomasz

AU - Wengrowicz, Sylvia

AU - Salvi, Mario

AU - Wall, Jack R.

PY - 1998

Y1 - 1998

N2 - Thyroid-associated ophthalmopathy (TAO) is a progressive orbital disorder associated with Graves' hyperthyroidism and, less often, Hashimoto's thyroiditis in which autoantibodies react with orbital antigens and lead to exophthalmos and eye muscle inflammation. Eye muscle (EM) membrane proteins initially reported as 55 and 64 kd are the best markers of ophthalmopathy. The '64-kd protein' is now shown to be the flavoprotein subunit of mitochondrial succinate dehydrogenase and to have a correct molecular weight of 67 kd. We have cloned a fragment of a novel eye muscle protein, which we call G2s, and sequenced 1.4 kb of the full length cDNA. G2s does not share any significant homologies with other reported proteins. The 5.9 kb G2s mRNA, that corresponds to a protein of approximately 220 kd, is expressed in EM, other skeletal muscle and thyroid, but not in other tissues tested. We have also cloned and sequenced a 63-kd eye muscle protein identified as the calcium binding protein calsequestrin. Antibodies against calsequestrin were found in 40% of patients with active ophthalmopathy, but in 0% of normal subjects. Finally, we have sequenced a 19 amino acid fragment of a 55-kd porcine eye muscle membrane protein that exactly matched porcine and human sarcalumenin, a 160-kd glycoprotein localized in the lumen of the longitudinal sarcoplasmic reticulum of the skeletal muscle fiber where it binds calcium. A 53-kd glycoprotein fragment of the molecule corresponds to the 55-kd protein. In a preliminary study, serum antibodies against purified sarcalumenin were detected in 40% of patients with active TAO of less than 1 year duration, but in no controls tested. We propose that the primary autoantigen in TAO is G2s, which would also explain the association of ophthalmopathy with thyroid autoimmunity, and that antibodies against the intracellular proteins flavoprotein, calsequestrin, and sarcalumenin are secondary markers of an immune-mediated reaction in eye muscle in patients with thyroid autoimmunity.

AB - Thyroid-associated ophthalmopathy (TAO) is a progressive orbital disorder associated with Graves' hyperthyroidism and, less often, Hashimoto's thyroiditis in which autoantibodies react with orbital antigens and lead to exophthalmos and eye muscle inflammation. Eye muscle (EM) membrane proteins initially reported as 55 and 64 kd are the best markers of ophthalmopathy. The '64-kd protein' is now shown to be the flavoprotein subunit of mitochondrial succinate dehydrogenase and to have a correct molecular weight of 67 kd. We have cloned a fragment of a novel eye muscle protein, which we call G2s, and sequenced 1.4 kb of the full length cDNA. G2s does not share any significant homologies with other reported proteins. The 5.9 kb G2s mRNA, that corresponds to a protein of approximately 220 kd, is expressed in EM, other skeletal muscle and thyroid, but not in other tissues tested. We have also cloned and sequenced a 63-kd eye muscle protein identified as the calcium binding protein calsequestrin. Antibodies against calsequestrin were found in 40% of patients with active ophthalmopathy, but in 0% of normal subjects. Finally, we have sequenced a 19 amino acid fragment of a 55-kd porcine eye muscle membrane protein that exactly matched porcine and human sarcalumenin, a 160-kd glycoprotein localized in the lumen of the longitudinal sarcoplasmic reticulum of the skeletal muscle fiber where it binds calcium. A 53-kd glycoprotein fragment of the molecule corresponds to the 55-kd protein. In a preliminary study, serum antibodies against purified sarcalumenin were detected in 40% of patients with active TAO of less than 1 year duration, but in no controls tested. We propose that the primary autoantigen in TAO is G2s, which would also explain the association of ophthalmopathy with thyroid autoimmunity, and that antibodies against the intracellular proteins flavoprotein, calsequestrin, and sarcalumenin are secondary markers of an immune-mediated reaction in eye muscle in patients with thyroid autoimmunity.

UR - http://www.scopus.com/inward/record.url?scp=0031835519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031835519&partnerID=8YFLogxK

M3 - Article

C2 - 9669297

AN - SCOPUS:0031835519

VL - 8

SP - 553

EP - 556

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 6

ER -